UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of earliest reported) |
August 22, 2001
|
|
Advanced Biotherapy, Inc.
(Exact name of registrant as specified in its chapter) |
| Delaware | 0-26323 | 95-0402415 | ||
|
|
||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 6355 Topanga Canyon Boulevard, Suite 510; Woodland Hills, California (Address of principal executive offices) |
91367
(Zip Code) |
| Registrant’s telephone number, including area code |
(818) 883-6716
|
| Item 5. OTHER EVENTS. | ||||||||
| Item 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| Signatures | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. OTHER EVENTS.
The registrant published a press release as of August 20, 2001, which announced that the registrant has received a “Notice of Allowance” from the United States Patent and Trademark Office for a utility patent for an antibody to treat autoimmune diseases. A copy of such press release is incorporated herein by reference and is attached as an exhibit to this Form 8-K.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
| (c) | Exhibits. |
| Designation | Description of Exhibit |
| 99.1 | Press Release, dated August 20, 2001 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED BIOTHERAPY, INC. (Registrant) |
||||
| | ||||
| Date: August 22, 2001 | By: | /s/ Edmond Buccellato | ||
| Edmond Buccellato, President | ||||
INDEX TO EXHIBITS
| Exhibit | Description | |
| 99.1 | Text of Press Release, dated August 20, 2001 |